BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)
Adaptor for ABI 3700 (AB-0800) from ABgene
Finnpipette Focus Multichannel 8 channel 5-50l from Thermo Scientific
Plasminogen Activator Inhibitor (PAI-1) Colorimetric Assay Kit from AMERICAN DIAGNOSTICA
Biology Products:..., ARTICLE #1 FOR IMMEDIATE RELEASE , Potential...rnal of the American Chemical Society , Chemists...ost powerful substance ever discovered for elimina...lead to the world,s first effective medicine for f...ug. Their findings are scheduled for the Sept. 24 ...
... PHILADELPHIA Researchers at Wayne State Universi...mpletely eliminated HER2-positive tumors in mice -...py - without any toxicity. , The study, reported ...journal of the American Association for Cancer Res... HER2-positive, treatment-resistant cancer or help...
... BOSTON--Demonstrating that despite the large numb...y more remain to be found, scientists at Dana-Farb...pected gene, CDK8, to colon cancer. , The discove...ew tools for assessing the activity of specific ge...ols are further improved, the stream of newly disc...
Other Biology News:American Chemical Society's Weekly PressPac -- Sept. 10, 2008 2American Chemical Society's Weekly PressPac -- Sept. 10, 2008 3American Chemical Society's Weekly PressPac -- Sept. 10, 2008 4American Chemical Society's Weekly PressPac -- Sept. 10, 2008 5American Chemical Society's Weekly PressPac -- Sept. 10, 2008 6American Chemical Society's Weekly PressPac -- Sept. 10, 2008 7American Chemical Society's Weekly PressPac -- Sept. 10, 2008 8Vaccine against HER2-positive breast cancer offers complete protection in lab 2Vaccine against HER2-positive breast cancer offers complete protection in lab 3Researchers identify cancer-causing gene in many colon cancers 2(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasda...pingandcommercializingnovelpainmanagementtherapies...fExecutiveOfficer,isscheduledtopresentatthe21stAnn...er1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork...alOfficer,willbeavailabletorespondtoquestionsdurin...
(Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc...icHealth,sExecutiveChairman,willpresentatthe21stAn...nTuesday,December1,2009at10:00a.m.ET. ,, Toacce...tation,visittheInvestorRelationssectionofGenomicHe....Pleaseconnecttothewebsiteatleast15minutespriortot...
(Date:11/24/2009)...RNewswire-FirstCall/--CellTherapeutics,Inc.(CTI)(N...ualPiperJaffrayHealthCareConference.Theconferencew... ,, CTIwillpresentonTuesday,December1at11:00a.m...fCTI,spresentationwillbeavailableat www.celltherap...wards. , ,PiperJaffrayHealthCareConference,NewYor...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2